Report #2850591

Received Jul 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 73 yrs
State: OK
Recovered: Unknown
Vaccinated: Jul 14, 2025
Onset: Jul 14, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	RA

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

the second today/ Wrong schedule; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on 28-APR-2023). On 14-JUL-2025, the patient received the 2nd dose of Shingrix (right arm). On 14-JUL-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: the second today/ Wrong schedule). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 14-JUL-2025 The Registered Nurse reported on behalf of a patient who received her first Shingrix vaccine on April 28th of 2023 and the second dose today which led to drug dose administration interval too long